design_sans_titre.jpg

Abivax secures € 15M non-dilutive financing from Kreos Capital

October 13, 2020

EUR 15M straight bonds, with no associated dilution, favorable financial conditions in interest rates and no expected transaction fees
Pre-negotiated EUR 5M additional straight bond tranche to be decided before 2020 year-end
Cash for operations extended until Q2 2021